Pancreatic Drug Trial Halted on Promising Results (HealthDay)
March 12, 2009 by Fred · Leave a Comment
(HealthDay) Drug maker Pfizer Inc. said Thursday that a late-stage clinical trial of its cancer drug Sutent has been stopped early, because it showed significant benefit for patients with a rare form of pancreatic cancer. Read more
